• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
TBIO

TBIO

Telesis Bio, Inc.

OTCHealthcareMedical - DevicesUS

USD0.05

+0.00 (+3.92%)

Company Profile

CEO

Eric Esser

IPO Date

2021-06-18

Sector

Healthcare

Industry

Medical - Devices

Exchange

OTC

Country

US

Market Metrics

Open

$0.05

Prev. Close

$0.05

Day Low

$0.05

Day High

$0.05

52W Low

$0.00

52W High

$1.55

Market Cap

$0.00B

Volume

0.00M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

50.8%

Avg Negative

1.6%

Avg Neutral

47.5%

News Feed

Sanofi (SNY)/Translate Bio Begin Study on mRNA Flu Vaccine

Zacks Investment Research·6/23/2021·↑ positive

Sanofi, Translate Bio Initiate Early-Stage mRNA Influenza Vaccine Trial

Benzinga·6/22/2021·↑ positive

Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of mRNA Influenza Vaccine

GlobeNewsWire·6/22/2021·↑ positive

Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program

GlobeNewsWire·6/7/2021·↑ positive

Translate Bio to Participate in Upcoming Investor Conferences

GlobeNewsWire·5/24/2021·↑ positive

Translate Bio's mRNA Therapeutic For Respiratory Tract Infections Shows Promise In Animal Studies

Benzinga·5/18/2021·↑ positive

Translate Bio Presents Preclinical Results in Primary Ciliary Dyskinesia (PCD) at American Thoracic Society (ATS) 2021 International Conference

GlobeNewsWire·5/18/2021·↑ positive

Translate Bio, Inc. (TBIO) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research·5/6/2021·↓ negative

Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit

GlobeNewsWire·4/28/2021·↑ positive

Translate Bio: New Management, Aggressive mRNA Pipeline Development, And Substantial Upside

Seeking Alpha·4/23/2021·↑ positive